Dose reduction and discontinuation of concomitant antiseizure medications after initiating cenobamate: A retrospective review

Pharmacokinetics of cenobamate as monotherapy compared with adjunctive therapy

(2023) Vijay Vashi et al.   EPILEPSY RESEARCH

Efficacy of cenobamate by focal seizure subtypes: Post-hoc analysis of a phase 3, multicenter, open-label study

(2022) William E. Rosenfeld et al.   EPILEPSY RESEARCH

Long-Term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures

(2022) Pavel Klein et al.   NEUROLOGY

Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations

(2022) Michael C. Smith et al.   Neurology and Therapy

Long‐term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open‐label extension of a randomized clinical study

(2021) Jacqueline A. French et al.   EPILEPSIA

Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications

(2021) William E. Rosenfeld et al.   EPILEPSIA

Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study

(2020) Michael R. Sperling et al.   EPILEPSIA

Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures

(2020) Steve S. Chung et al.   NEUROLOGY

Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial

(2019) Gregory L Krauss et al.   LANCET NEUROLOGY

Clinical risk factors in SUDEP

(2019) Olafur Sveinsson et al.   NEUROLOGY

Effect of reduction of antiepileptic drugs in patients with drug-refractory epilepsy

(2015) Deepa Dash et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Adverse effects of antiepileptic drugs

(2012) Piero Perucca et al.   LANCET NEUROLOGY

Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments

(2011) Chiara Luoni et al.   EPILEPSIA